1,648
Views
2
CrossRef citations to date
0
Altmetric
research paper

Apremilast mitigates interleukin (IL)-13-induced inflammatory response and mucin production in human nasal epithelial cells (hNECs)

, , , &
Pages 8583-8593 | Received 13 Jul 2021, Accepted 28 Sep 2021, Published online: 18 Oct 2021

References

  • Hoyte FCL, Nelson HS. Recent advances in allergic rhinitis. F1000Res. 2018;7.
  • Incorvaia C, Cavaliere C, Frati F, et al. Allergic rhinitis. J Biol Regul Homeost Agents. 2018;32:61–66.
  • Pablos I, Wildner S, Asam C, et al. Pollen allergens for molecular diagnosis. Curr Allergy Asthma Rep. 2016;16:31.
  • Valenta R, Karaulov A, Niederberger V, et al. Molecular aspects of allergens and allergy. Adv Immunol. 2018;138:195–256.
  • Huang ZL, Ong KL, Goh SY, et al. Assessment of nasal cycle by acoustic rhinometry and rhinomanometry. Otolaryngol Head Neck Surg. 2003;128:510–516.
  • Zhang LX, Liu T. [Treg influences the pathogenesis of allergic rhinitis through TICAM-1 pathway]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018;32:1763.
  • Van Nguyen T, Piao CH, Fan YJ, et al. Anti-allergic rhinitis activity of alpha-lipoic acid via balancing Th17/Treg expression and enhancing Nrf2/HO-1 pathway signaling. Sci Rep. 2020;10:12528.
  • Ochiai S, Jagot F, Kyle RL, et al. Thymic stromal lymphopoietin drives the development of IL-13(+) Th2 cells. Proc Natl Acad Sci U S A. 2018;115:1033–1038.
  • Ashraf MI, Shahzad M, Shabbir A. Oxyresveratrol ameliorates allergic airway inflammation via attenuation of IL-4, IL-5, and IL-13 expression levels. Cytokine. 2015;76:375–381.
  • Wang WW, Zhu K, Yu HW, et al. Interleukin-17A potentiates interleukin-13-induced eotaxin-3 production by human nasal epithelial cells from patients with allergic rhinitis. Int Forum Allergy Rhinol. 2019;9:1327–1333.
  • Wang L, Lv Q, Song X, et al. ADRB2 suppresses IL-13-induced allergic rhinitis inflammatory cytokine regulated by miR-15a-5p. Hum Cell. 2019;32:306–315.
  • Hong Z, Guo Z, Zhang R, et al. Airborne fine particulate matter induces oxidative stress and inflammation in human nasal epithelial cells. Tohoku J Exp Med. 2016;239:117–125.
  • Majima Y, Hirata K, Takeuchi K, et al. Effects of orally administered drugs on dynamic viscoelasticity of human nasal mucus. Am Rev Respir Dis. 1990;141:79–83.
  • Borchers MT, Wert SE, Leikauf GD. Acrolein-induced MUC5ac expression in rat airways. Am J Physiol. 1998;274:L573–81.
  • Temann UA, Prasad B, Gallup MW, et al. A novel role for murine IL-4 in vivo: induction of MUC5AC gene expression and mucin hypersecretion. Am J Respir Cell Mol Biol. 1997;16:471–478.
  • Shi Z, Xu M, Chen X, et al. The regulatory role of SFRP5/WNT5A axis in allergic rhinitis through inhibiting JNK pathway activation and lowering mucin generation in human nasal epithelial cells. Exp Mol Pathol. 2021;118:104591.
  • Yang Y, Zhang Y, Yang Y, et al. Differential expression of long noncoding RNAs and their function-related mRNAs in the peripheral blood of allergic rhinitis patients. Am J Rhinol Allergy. 2020;34:508–518.
  • Subedi L, Lee JH, Yumnam S, et al. Anti-inflammatory effect of sulforaphane on LPS-activated microglia potentially through JNK/AP-1/NF-kappaB inhibition and Nrf2/HO-1 activation. Cells. 2019;8.
  • Poole RM, Ballantyne AD. Apremilast: first global approval. Drugs. 2014;74:825–837.
  • Zhen G, Park SW, Nguyenvu LT, et al. IL-13 and epidermal growth factor receptor have critical but distinct roles in epithelial cell mucin production. Am J Respir Cell Mol Biol. 2007;36(2):244–253.
  • Zhang Y, Huang X, Yuan Y. Anti-inflammatory capacity of Apremilast in human chondrocytes is dependent on SOX-9. Inflamm Res. 2020;69(11):1123–1132.
  • Zhu HT, Chen H, Ding DG, et al. The interaction of miR-181a-5p and sirtuin 1 regulated human bone marrow mesenchymal stem cells differentiation and apoptosis. Bioengineered. 2021;12(1):1426–1435.
  • Zhang J, Zheng ZQ, Xu Q, et al. Onopordopicrin from the new genus Shangwua as a novel thioredoxin reductase inhibitor to induce oxidative stress-mediated tumor cell apoptosis. J Enzyme Inhib Med Chem. 2021;36(1):790–801.
  • Mavropoulos A, Zafiriou E, Simopoulou T, et al. Apremilast increases IL-10-producing regulatory B cells and decreases proinflammatory T cells and innate cells in psoriatic arthritis and psoriasis. Rheumatology (Oxford). 2019;58:2240–2250.
  • Chen L, Xu JJ, Deng MY, et al. Telmisartan mitigates lipopolysaccharide (LPS)-induced production of mucin 5AC (MUC5AC) through increasing suppressor of cytokine signaling 1 (SOCS1). Bioengineered. 2021;12(1):3912–3923.
  • Devereux S, Linch DC. Granulocyte-macrophage colony-stimulating factor. Biotherapy. 1990;2:305–313.
  • Legler DF, Thelen M. Chemokines: chemistry, biochemistry and biological function. Chimia (Aarau). 2016;70:856–859.
  • Wang W, Zheng M. Mucin 5 subtype AC expression and upregulation in the nasal mucosa of allergic rhinitis rats. Otolaryngol Head Neck Surg. 2012;147:1012–1019.
  • Tsou YA, Lin CD, Chen HC, et al. Interleukin-13 inhibits lipopolysaccharide-induced BPIFA1 expression in nasal epithelial cells. PLoS One. 2015;10:e0143484.
  • Chen T, Zhang X, Zhu G, et al. Quercetin inhibits TNF-alpha induced HUVECs apoptosis and inflammation via downregulating NF-kB and AP-1 signaling pathway in vitro. Medicine (Baltimore). 2020;99:e22241.
  • Kim HJ, Park YD, Moon UY, et al. The role of Nox4 in oxidative stress-induced MUC5AC overexpression in human airway epithelial cells. Am J Respir Cell Mol Biol. 2008;39:598–609.
  • Nadeem A, Masood A, Siddiqui N. Oxidant–antioxidant imbalance in asthma: scientific evidence, epidemiological data and possible therapeutic options. Ther Adv Respir Dis. 2008;2:215–235.
  • Deepak P, Kumar S, Acharya A. Interleukin-13 neutralization modulates interleukin-13 induced suppression of reactive oxygen species production in peritoneal macrophages in a murine T-cell lymphoma. Cell Immunol. 2008;251:72–77.
  • Slimen IB, Najar T, Ghram A, et al. Reactive oxygen species, heat stress and oxidative-induced mitochondrial damage. A review. Int J Hyperthermia. 2014;30:513–523.
  • Islam MT. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders. Neurol Res. 2017;39:73–82.
  • Tukler Henriksson J, Coursey TG, Corry DB, et al. IL-13 stimulates proliferation and expression of mucin and immunomodulatory genes in cultured conjunctival goblet cells. Invest Ophthalmol Vis Sci. 2015;56:4186–4197.
  • Ma B, Liu W, Homer RJ, et al. Role of CCR5 in the pathogenesis of IL-13-induced inflammation and remodeling. J Immunol. 2006;176:4968–4978.
  • Bertrand CA, Danahay H, Poll CT, et al. Niflumic acid inhibits ATP-stimulated exocytosis in a mucin-secreting epithelial cell line. Am J Physiol Cell Physiol. 2004;286:C247–55.
  • Hauber HP, Daigneault P, Frenkiel S, et al. Niflumic acid and MSI-2216 reduce TNF-alpha-induced mucin expression in human airway mucosa. J Allergy Clin Immunol. 2005;115:266–271.
  • von Knethen A, Callsen D, Brune B. NF-kappaB and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages. Mol Biol Cell. 1999;10:361–372.
  • Finkenzeller G, Technau A, Marme D. Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. Biochem Biophys Res Commun. 1995;208:432–439.
  • Jain J, Valge-Archer VE, Rao A. Analysis of the AP-1 sites in the IL-2 promoter. J Immunol. 1992;148:1240–1250.